»Æ¹ÏÊÓƵapp

With the explosion of different modalities and the incredible speed and potential of the AI/ML revolution, partnerships between platform companies and larger pharma are more critical than ever to accelerate drug development. John Lepore, CEO of ProFound Therapeutics and CEO-Partner, »Æ¹ÏÊÓƵapp, Mike Nally, CEO of Generate:Biomedicines and CEO-Partner, »Æ¹ÏÊÓƵapp, and Luciano Rossetti, Chief Medical Officer, »Æ¹ÏÊÓƵapp and Head of Research & Development, Pioneering Medicines join Amanda Kay, Chief Business Development Officer and Senior Partner, »Æ¹ÏÊÓƵapp to discuss the opportunity that Flagship’s innovative bioplatforms offer in terms of novel partnerships with pharma to bring about new therapeutics. More from Flagship @ JPM2024 here.